ADMS β€” ADAMAS PHARMACEUTICALS INC

Ownership history in Stonepine Capital Management, LLC  Β·  11 quarters on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in ADAMAS PHARMACEUTICALS INC (ADMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
8.86% (2021 Q1)
πŸ“Š Avg. % of fund
5.37%
πŸ“… First filed
2019 Q1
πŸ“… Last filed
2021 Q3
⏱ Quarters held
11
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2021 Q3 ADDED 3,914,938 +496,659 +14.5% 8.75% $19.2M β€”
2021 Q2 UNCHANGED 3,418,279 β€” 0% 8.86% $16.4M β€”
2021 Q1 ADDED 3,418,279 +2,609,848 +322.8% 8.86% $16.4M β€”
2020 Q4 ADDED 808,431 +150,964 +23.0% 2.68% $3.5M β€”
2020 Q3 REDUCED 657,467 -100,237 -13.2% 2.82% $2.7M β€”
2020 Q2 REDUCED 757,704 -405,172 -34.8% 3.76% $1.9M β€”
2020 Q1 REDUCED 1,162,876 -1,078,363 -48.1% 3.55% $3.4M β€”
2019 Q4 ADDED 2,241,239 +1,490,227 +198.4% 5.92% $8.5M β€”
2019 Q3 REDUCED 751,012 -672,566 -47.2% 3.73% $3.8M β€”
2019 Q2 ADDED 1,423,578 +439,249 +44.6% 6.08% $8.8M β€”
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history
← Back to Stonepine Capital Management, LLC Holdings